Clinical Trial Detail

NCT ID NCT01888965
Title Maintenance Dovitinib for Colorectal and Pancreas Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Georgetown University|Novartis
Indications

colorectal cancer

pancreatic cancer

Therapies

Dovitinib

Age Groups: adult

No variant requirements are available.